STAQ Pharma key facts
- Operator of an FDA-registered outsourcing facility intended to provide safe, reliable, and high-quality compounded medications to healthcare providers.
- It has raised $95.8M across 4 recorded rounds; the latest was Early Stage VC ($11.4M) in Sep 2024.
- Notable investors include JobsOhio Ventures, Rev1 Ventures, Stout Street Capital, Colorado Office of Economic Development & International Trade, University Hospitals Ventures — 13 tracked in total.
- STAQ Pharma has filed 9 Form Ds with the SEC since 2019, most recently Sep 2024 ($11.4M sold to 8 investors).
- Status: Privately Held (backing).
Who backs STAQ Pharma
13+Membership and data by Private Market View
- ·The complete investor list: 13 names
- ·Watch STAQ Pharma: the Monday email on marks, rounds and moves
STAQ Pharma funding rounds
4 roundsHow much has STAQ Pharma raised?
STAQ Pharma has raised $95.8 million across 4 recorded rounds since 2019. The largest was a $9 million early-stage round in Apr 2019; the most recent was an $11.4 million early-stage round in Sep 2024.
STAQ Pharma has filed 9 Form Ds with the SEC since 2019, most recently in Sep 2024 ($11.4 million sold to 8 investors).
STAQ Pharma investors
13 investors are on record for STAQ Pharma, including JobsOhio Ventures, Rev1 Ventures, Stout Street Capital and Colorado Office of Economic Development & International Trade. The early-stage round in Sep 2024 drew 8 investors.
About STAQ Pharma
Operator of an FDA-registered outsourcing facility intended to provide safe, reliable, and high-quality compounded medications to healthcare providers. The company offers sterile, ready-to-use injectable drugs produced in CGMP-compliant facilities with rigorous quality controls, enabling hospitals and health systems to maintain consistent access to essential medications and ensure patient safety.
- Sector
- Healthcare
- HQ
- Denver, CO, United States
- Founded
- 2010
- Employees
- 93
- Website
- staqpharma.com/
- Ownership
- Privately Held (backing)
Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.
STAQ Pharma doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.